Orrin Hatch: “So, with all of these tools in FDA's arsenal, legitimate questions have been raised about why unsafe or mislabeled…”

I urge Congress pass the OPEN ACT before the end of this year.

It has been one of the great honors of my life to serve on this committee.

Those backlogs at the Social Security Administration are unacceptable to many, if not most, of us here in the Senate.

I say, 'damn right.'